索引超出了数组界限。
[1] Simona A, Limacher A, Méan M, et al. High-sensitive cardiac
troponin T as a marker of hemorrhagic complications in
elderly patients anticoagulated for non-massive pulmonary
embolism[J]. Thromb Res, 2020, 185(6):5-12.
[2] Akkurt G, Akkurt B, Alptekn E, et al. Efficacy of thiol
disulfide homeostasis and ischemia modified albumin
values in estimating the degree of difficulty for laparoscopic
cholecystectomy[J]. Comb Chem High Throughput Screen,
2021, 24(3):433-440.
[3] Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA
guidelines for the management of patients with ST-elevation
myocardial infarction; A report of the American College
of Cardiology/American Heart Association Task Force on
Practice Guidelines (Committee to Revise the 1999 Guidelines
for the management of patients with acute myocardial
infarction)[J]. J Am Coll Cardiol, 2004, 44(3):E1-E211.
[4] 马芳涛, 张小玲. STEMI患者血浆BNP,同型半胱氨酸水平
与心肌损伤标记物及冠脉病变程度的相关性[J]. 山东医药,
2017, 57(33):12-15.
[5] Xiang L, Zhang M, Wu H, et al. The expression and prognostic
value of ischemia modified albumin (IMA), red blood cell
distribution width (RDW), and lipoprotein (LP) in patients
with diabetes mellitus complicated with coronary heart
disease[J]. Ann Palliat, Med, 2021, 10(4):4463-4471.
[6] Pipikos T, Kapelouzou A, Tsilimigras DI, et al. Stronger
correlation with myocardial ischemia of high-sensitivity
troponin T than other biomarkers[J]. J Nucl Cardiol, 2019,
26(5):1674-1683.
[7] 王紫监, 陈敏, 梁晶, 等. 同型半胱氨酸,缺血修饰蛋白与非
ST段抬高急性心肌梗死患者冠状动脉病变程度的关系[J].
山东医药, 2014, 54(39):62-64.
[8] 章丽珠, 韩志君, 刘肖肖, 等. 缺血修饰蛋白对急性冠脉综合
征的诊断价值[J]. 实用医学杂志, 2019, 35(14):2321-2323.
[9] 紫净, 余陆娇, 张子新. 急性冠状动脉综合征患者缺血修饰
白蛋白水平与冠状动脉病变程度的相关性研究[J]. 中国医
科大学学报, 2017, 46(11):1009-1012.